SOURCE: slp3D

May 23, 2006 07:15 ET

REMINDER: OR-Live.com Presents: Leading Edge Minimally Invasive Pituitary Surgery From Thomas Jefferson University Hospital

Breakthrough Procedure Allows Doctors to Remove Brain Tumors Through Nose and Nasal Sinuses -- Live Webcast May 23, 2006 at 4:30 PM EDT (20:30 UTC)

PHILADELPHIA, PA -- (MARKET WIRE) -- May 23, 2006 -- Jefferson will host a webcast featuring the newest approach for the removal of pituitary tumors -- minimally invasive endoscopic pituitary surgery -- on Tuesday, May 23, 2006, at 4:30 pm. Viewers will also be able to ask questions online of the surgical team during the surgery.

Jefferson experts in Neurosurgery and Otolaryngology -- Head & Neck Surgery will perform this procedure through the nasal passages and sinus cavities without external incisions. New state-of-the-art technology has allowed for improved visualization and access to these difficult tumors which has resulted in a shorter hospital stay, a faster recovery and improved outcomes.

Using an endoscope with a camera attached, surgeons enter a patient's nose and sinuses, allowing them to approach the tumor without any external incisions. Guided by the endoscope and enhanced computer navigation, surgeons open small holes in the base of the skull and membrane covering the brain to remove the tumor. Better visualization and access to these lesions have enabled improved resection of the tumor without causing damage to the brain and lower risk of complications and follow up surgery.

Co-directors of the Jefferson Center for Minimally Invasive Cranial Base Surgery and Endoscopic Neurosurgery, Marc Rosen, M.D., Otolaryngology -- Head & Neck Surgery, and James Evans, M.D., Neurosurgery, will perform the procedure. David W. Andrews, M.D., Professor and Vice Chair of Neurosurgery, will narrate.

"The webcast will allow both patients and colleagues to see this leading edge surgical technique that gives us a new way to treat patients with benign and malignant brain, cranial base and sino-nasal tumors," said Dr. Rosen.

Patients with a variety of skull base tumors including pituitary tumors, craniopharyngiomas, chordomas, chondrosarcomas, meningiomas, sino-nasal malignancies, juvenile nasal angiofibroma, cerebrospinal fluid leaks, meningoceles, encephaloceles, colloid cysts, as well as other intracranial and intraventricular tumors can benefit from this approach.

Continuing Medical Education (CME) credits are available.

Visit http://www.or-live.com/jeffersonhospital/1346 now to view a program preview.

VNR: www.OR-Live.com/rams/thj-1346-mkw.q.ram

This Webcast will be simulcast live by the National Library of Medicine's MedlinePlus.gov

Contact Information

  • Contact:

    Alex Fraser
    Director of Marketing
    slp3D, Inc / OR-Live
    860-953-2900 x 214
    afraser@slp3d.com